Literature DB >> 18525371

Unexplained deaths in Connecticut, 2002-2003: failure to consider category a bioterrorism agents in differential diagnoses.

John P Palumbo1, James I Meek, Darcy M Fazio, Susan B Turner, James L Hadler, André N Sofair.   

Abstract

BACKGROUND: Recognition of bioterrorism-related infections by hospital and emergency department clinicians may be the first line of defense in a bioterrorist attack.
METHODS: We identified unexplained infectious deaths consistent with the clinical presentation of anthrax, tularemia, smallpox, and botulism using Connecticut death certificates and hospital chart information. Minimum work-up criteria were established to assess the completeness of diagnostic testing.
RESULTS: Of 4558 unexplained infectious deaths, 133 were consistent with anthrax (2.9%) and 6 (0.13%) with tularemia. None were consistent with smallpox or botulism. No deaths had anthrax or tularemia listed in the differential diagnosis or had disease-specific serology performed. Minimum work-up criteria were met for only 53% of cases.
CONCLUSIONS: Except for anthrax, few unexplained deaths in Connecticut could possibly be the result of the bioterrorism agents studied. In 47% of deaths from illnesses that could be anthrax, the diagnosis would likely have been missed. As of 2004, Connecticut physicians were not well prepared to intentionally or incidentally diagnose initial cases of anthrax or tularemia. More effective clinician education and surveillance strategies are needed to minimize the potential to miss initial cases in a bioterrorism attack.

Entities:  

Mesh:

Year:  2008        PMID: 18525371     DOI: 10.1097/DMP.0b013e318161315b

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


  1 in total

1.  Pandemic (H1N1) 2009-associated deaths detected by unexplained death and medical examiner surveillance.

Authors:  Christine H Lees; Catherine Avery; Ryan Asherin; Jean Rainbow; Richard Danila; Chad Smelser; Ann Schmitz; Stephen Ladd-Wilson; Kurt B Nolte; Kayla Nagle; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.